Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 247 clinical trials
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease

The aim of this clinical study is to assess the prognostic value of radiotracer-based perfusion imaging for predicting clinical outcomes in diabetic patients with peripheral arterial disease

obstructive disease
vascular disease
angiography
computed tomography angiography
revascularisation
  • 10 views
  • 12 Feb, 2022
  • 1 location
Telehealth Exercise Training in Peripheral Arterial Disease - TEXT-PAD

Peripheral arterial disease is a common, undertreated and under-researched issue. The vast majority of these patients often have multiple issues which can be improved with targeted behavioural

intermittent claudication
  • 0 views
  • 07 Mar, 2022
Effects of Heating on Exercise Pressor Reflex in Peripheral Artery Disease: Exercise Ability (EPR)

with peripheral artery disease, via altering the sensitivity of the muscle afferent receptors.

Accepts healthy volunteers
vascular disease
arteriopathy
peripheral arterial diseases
  • 0 views
  • 23 Mar, 2022
  • 1 location
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss (PROVE)

The PROVE Trial is a randomized clinical trial that will determine whether a weight loss intervention combined with walking exercise achieves greater improvement or less decline in six-minute walk distance at 12 month follow-up than walking exercise alone in people with PAD and BMI>28 kg/m2. The intervention uses a Group …

arteriopathy
peripheral arterial diseases
  • 20 views
  • 25 Mar, 2022
  • 1 location
Adapted Physical Activity in Patients With Lower Limb Peripheral Arterial Disease

The prevalence of peripheral arterial disease is 12.2% in France. Intermittent claudication is the most common symtom of this disease. During physical exercise, such as walking, blood oxygen (O2

  • 0 views
  • 24 Mar, 2021
  • 1 location
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

The vanguard phase of the Low dose ColchicinE in pAtients with peripheral Artery DiseasE to address residual vascular Risk (LEADER-PAD) trial will evaluate the feasibility of conducting a full

  • 0 views
  • 28 Sep, 2021
  • 1 location
Sirolimus- vs. Paclitaxel-Drug Coated Ballons in Patients With Peripheral Artery Disease (SIRONA)

This study is a prospective, interventional, multi-center 1:1 randomized non-inferiority trial. The trial evaluates the safety and efficacy of the Magic Touch PTA sirolimus drug-coated balloon in comparison to the treatment with PTX drug-coated balloon (control device) in patients with femoropopliteal artery disease.

  • 0 views
  • 13 Mar, 2022
  • 10 locations
Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease

to walking exercise + sham compression therapy, in people with lower extremity peripheral artery disease (PAD). The INTERCEDE trial will also determine whether intermittent pneumatic compression

stenosis
arteriopathy
peripheral arterial diseases
  • 0 views
  • 23 Aug, 2021
  • 1 location
Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease (NICE)

NICE is a randomized clinical trial that will examine the effects of nicotinamide riboside (NR) both with and without resveratrol to test whether, among people with PAD, NR significantly improves walking performance more than placebo and whether NR combined with resveratrol significantly improves walking performance more than placebo. If our …

arteriopathy
peripheral arterial diseases
  • 151 views
  • 11 May, 2022
  • 1 location
Improving Mobility in Peripheral Artery Disease Using an Ankle Foot Orthosis

This study will determine whether an ankle foot orthosis (AFO) improves walking performance in patients with PAD from its first use. Additionally, the study will test walking performance after a three month AFO intervention and will examine the feasibility of this AFO intervention. Data for evaluations will be collected from …

Accepts healthy volunteers
intermittent claudication
diabetes
arteriopathy
peripheral arterial diseases
  • 4 views
  • 06 May, 2022
  • 1 location